Expert lung cancer care in southwest Virginia

LewisGale Regional Health System has some of the nation’s best cancer specialists–in locations convenient to where you live–ready to screen for, diagnose and treat lung cancer using the latest medical knowledge and technology.

For more information about our lung cancer care, call Consult-A-Nurse® at (877) 242-2362.

Lung cancer diagnosis

Our physicians specializing in pulmonary care use leading-edge testing to diagnose lung cancer. Diagnostic tools used to confirm the presence of cancerous cells may include:

  • Bronchoscopy
  • Navigational bronchoscopy
  • Mediastinoscopy
  • Computed tomography (CT) guided biopsy
  • Positron emission tomography (PET)
  • PET/CT scan
  • Chest X-ray
  • Spiral CT scan
Find locations for this service on our Oncology page

Lung cancer screening

Screening is designed to detect the presence of lung cancer before symptoms arise when cancer treatment can lead to the best results possible.

Screening is a particularly important consideration for:

  • Adults 55 to 74 years old with a history of smoking a pack of cigarettes a day for 30 years or more
  • Current smokers
  • Former smokers who have quit in the last 15 years

If you or a loved one are at risk, talk with your physician today about whether a lung cancer screening at LewisGale Regional Health System is right for you.

Take our free lung cancer risk assessment

Lung cancer treatment

Treating lung cancer depends on a number of patient and disease-specific factors. Some of the treatment options offered through the LewisGale Regional Health System oncology program include:

  • Tracheal and bronchial stenting
  • Surgery
  • Chemotherapy
  • Immunotherapy
  • Targeted drug therapy
  • Laser therapy
  • Cryotherapy
  • Interventional radiology
  • Radiation therapy, available at LewisGale Pulaski and LewisGale Salem

Clinical trials for lung cancer

At LewisGale Regional Health System, we're committed to providing you with the most advanced lung cancer treatments possible. This is why we participate in cancer research and trials for lung cancer. We also actively collect data through cancer data registries to improve treatment plans and measure quality outcomes.